Stockholders’ Equity - Schedule of Warrant Transactions (Details) - Warrant [Member] - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Schedule of Warrant Transactions [Line Items] | ||
| Number of Shares, Outstanding Beginning Balance | 70,000,000 | 87,500,000 |
| Weighted Average Exercise Price, Outstanding Beginning Balance | $ 0.1 | $ 0.091 |
| Number of Shares, Granted | 12,526,461 | |
| Weighted Average Exercise Price, Granted | $ 0.0001 | |
| Number of Shares, Exercised | ||
| Weighted Average Exercise Price, Exercised | ||
| Number of Shares, Expired | (17,500,000) | |
| Weighted Average Exercise Price, Expired | $ (0.055) | |
| Number of Shares, Outstanding Ending Balance | 82,526,461 | 70,000,000 |
| Weighted Average Exercise Price, Outstanding Ending Balance | $ 0.08 | $ 0.1 |
| X | ||||||||||
- Definition Weighted average exercise price, expired. No definition available.
|
| X | ||||||||||
- Definition Represent the share based compensation arrangement by share based payment award equity instruments other than options Expired in period weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Number of shares underlying warrants, exercised. No definition available.
|
| X | ||||||||||
- Definition Number of shares underlying warrants, expired. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|